Saturday, May 10, 2025
Home Authors Posts by Editor / Curator

Editor / Curator

941 POSTS 0 COMMENTS
All News

MySize (MYSZ) CEO Ron Luzon. Interview. (Bloomberg)

Editor / Curator -
nanovibronix, biotech stock review
Biotech News

Biotech Stock Review Adds NanoVibronix (NAOV) $2.95, to Watch List.

Editor / Curator -
Israel tech stocks
Israel

Israeli Tech Stocks Raise $165 Million on Toronto TSX, Bypassing NASDAQ.

Editor / Curator -
Internet Stock Review
Featured

Baltimore’s $10 Million Problem is Just the Tip of the Iceberg.

Editor / Curator -
Research

Mustang Bio (MBIO) $3.40 Gets $7 Price Target from Cantor. (SeekingAlpha.)

Editor / Curator -
redefy
IPOS

Redefy Corporation* (RDCO) Announces Up to $6 Million Private Securities Offering.

Editor / Curator -
orchestra biomed
Biotech News

Orchestra BioMed™ Announces Global Strategic Partnership with Terumo Corporation.

Editor / Curator -
ecuador gold
Precious Metals

Ecuador: The Largest Gold Rush in History? Initiating Coverage on Lucky...

Editor / Curator -
Institutional Gold Research
Precious Metals

Is Gold $50 Away From a Domino Effect From a Flood...

Editor / Curator -
hotel communication network
Internet News

HCN to Showcase how Hotels can Save up to $50 per...

Editor / Curator -
1...828384...95Page 83 of 95

Latest article

Zomedica Corp (ZOMDF) $0.05

Uncategorized Editor / Curator -
Company Overview Background Zomedica Corp., incorporated in 2013 under the Business Corporations Act (Alberta), is...

Gold prices plunge in biggest one-day drop in years. Is the record rally over?...

All News Editor / Curator -
Easing anxieties over Trump’s tariff policies and the Fed chair’s fate spark gold’s worst daily decline since 2021 Gold...

Gold Price Sets New Intraday Record Above $3,500 (WSJ)

All News Editor / Curator -
Gold hit another record Tuesday, then faded a bit in afternoon trading. The most actively traded futures contracts surged...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.